Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention
Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk f...
Saved in:
Published in | Atherosclerosis Vol. 263; pp. 343 - 351 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.08.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9150 1879-1484 1879-1484 |
DOI | 10.1016/j.atherosclerosis.2017.06.001 |
Cover
Abstract | Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.
[Display omitted]
•Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide.•CVD and cancer have common risk factors and shared genetics and molecular mechanisms that are central to their pathogenesis.•The shared pathways of CVD and cancer are potential targets for development of novel drugs for joint pharmacologic prevention of CVD and cancer.•A growing body of evidence supports a role for aspirin, statins, ACE inhibitors/ARBs, metformin, and TZDs in cancer prevention.•Both pharmacologic and non-pharmacologic preventive programs should be directed jointly at CVD and cancer. |
---|---|
AbstractList | Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization’s joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. Abstract Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help to identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention.Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. [Display omitted] •Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide.•CVD and cancer have common risk factors and shared genetics and molecular mechanisms that are central to their pathogenesis.•The shared pathways of CVD and cancer are potential targets for development of novel drugs for joint pharmacologic prevention of CVD and cancer.•A growing body of evidence supports a role for aspirin, statins, ACE inhibitors/ARBs, metformin, and TZDs in cancer prevention.•Both pharmacologic and non-pharmacologic preventive programs should be directed jointly at CVD and cancer. |
Author | Mani, Arya Masoudkabir, Farzad Gotay, Carolyn Franco, Christopher Davis, Margot K. Sarrafzadegan, Nizal Ignaszewski, Andrew Krahn, Andrew D. |
AuthorAffiliation | c School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada d Cancer Control Research Program, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada b Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran e Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada f Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA a Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran |
AuthorAffiliation_xml | – name: c School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada – name: d Cancer Control Research Program, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada – name: a Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran – name: e Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada – name: b Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran – name: f Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA |
Author_xml | – sequence: 1 givenname: Farzad surname: Masoudkabir fullname: Masoudkabir, Farzad organization: Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Nizal surname: Sarrafzadegan fullname: Sarrafzadegan, Nizal email: nsarrafzadegan@gmail.com organization: Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran – sequence: 3 givenname: Carolyn surname: Gotay fullname: Gotay, Carolyn organization: School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 4 givenname: Andrew surname: Ignaszewski fullname: Ignaszewski, Andrew organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 5 givenname: Andrew D. surname: Krahn fullname: Krahn, Andrew D. organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 6 givenname: Margot K. surname: Davis fullname: Davis, Margot K. organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 7 givenname: Christopher surname: Franco fullname: Franco, Christopher organization: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 8 givenname: Arya surname: Mani fullname: Mani, Arya organization: Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28624099$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkt-LEzEQx4OceL3Tf0H2RfBla5Luj0RQkFJP4cAH9TmMk-w1NU3WZLdH_3uz9uzpgWBfMoGZfGbyne8FOfPBG0JeMDpnlDWvNnMY1iaGhG46bZpzyto5beaUskdkxkQrS1aJ6ozMKOWslKym5-QipQ2ltGqZeELOuWh4RaWcEb2EqG3YQcLRQSy0TQaSKcDrAsGjia-L1c5qk69FF2KR1hCNPtb1eZpb2KdfD_qc2wIGF24sFn00O-MHG_xT8rgDl8yzu3hJvr5ffVl-KK8_XX1cvrsusWHNUCJoJupOoO7qruMIpkOUQrdctAyrBuu6EjmC0LptJDQ157rmclGLSnd6sbgkbw_c0fewvwXnVB_tFuJeMaom-dRGPZBPTfIp2qgs3z2gH79tjcY8foR7SACr_s54u1Y3YacaTltZ8Qx4eQeI4cdo0qC2NqFxDrwJY1JMMsakEELm0ud_9jo2-b2bXLA8FGAeNEXTKbQDTHrm1tb995fePKCcKsnV4b3Ji9tZE1VCO7lB22hwUDrYU8U9ktBZbxHcd7M3aRPG6LM7FFOJK6o-T-6dzMvaBeXZ0Bmw-jfghEF-Au5NDsU |
CitedBy_id | crossref_primary_10_35366_95587 crossref_primary_10_1016_j_lfs_2023_122244 crossref_primary_10_2459_JCM_0000000000000701 crossref_primary_10_2139_ssrn_4046665 crossref_primary_10_1177_2047487319895415 crossref_primary_10_1200_OP_20_01053 crossref_primary_10_1016_j_medcli_2023_01_007 crossref_primary_10_1016_j_lpmfor_2023_10_020 crossref_primary_10_1016_j_medcle_2023_01_012 crossref_primary_10_1016_j_jaccao_2023_05_007 crossref_primary_10_3390_jcm10112451 crossref_primary_10_3389_fcvm_2021_690533 crossref_primary_10_1016_j_numecd_2019_11_016 crossref_primary_10_1016_j_thromres_2022_01_003 crossref_primary_10_3390_pharmaceutics13060766 crossref_primary_10_1159_000514207 crossref_primary_10_1007_s11886_023_01906_6 crossref_primary_10_1093_ehjci_jead168 crossref_primary_10_3390_jcm13102887 crossref_primary_10_1186_s12885_020_07487_9 crossref_primary_10_1002_nbm_4845 crossref_primary_10_1016_j_nanoen_2024_109519 crossref_primary_10_3390_ijms252313185 crossref_primary_10_1177_00033197231152693 crossref_primary_10_1002_cncr_32085 crossref_primary_10_1016_j_bbrc_2018_12_160 crossref_primary_10_1016_j_ejim_2020_05_034 crossref_primary_10_2174_1573407219666230907115809 crossref_primary_10_1096_fj_202500198R crossref_primary_10_21518_1561_5936_2019_12_36_43 crossref_primary_10_12997_jla_2025_14_1_30 crossref_primary_10_1158_0008_5472_CAN_18_1677 crossref_primary_10_1016_j_pcad_2019_02_002 crossref_primary_10_1186_s12967_023_04680_9 crossref_primary_10_3389_fonc_2021_731249 crossref_primary_10_1055_a_2052_5681 crossref_primary_10_2147_CLEP_S262939 crossref_primary_10_1016_j_jaccao_2023_01_004 crossref_primary_10_1016_j_jacc_2020_03_067 crossref_primary_10_3390_jcm12185804 crossref_primary_10_1053_j_jvca_2020_02_052 crossref_primary_10_1016_j_jjcc_2022_03_013 crossref_primary_10_1016_j_mrrev_2020_108348 crossref_primary_10_1080_14740338_2022_1986001 crossref_primary_10_1038_s41598_019_39004_9 crossref_primary_10_12997_jla_2025_14_1_22 crossref_primary_10_1016_j_cpcardiol_2021_100958 crossref_primary_10_1186_s41043_023_00356_8 crossref_primary_10_1093_database_baad029 crossref_primary_10_1016_j_ajpc_2024_100926 crossref_primary_10_3389_fcvm_2023_1274976 crossref_primary_10_1159_000515473 crossref_primary_10_18786_2072_0505_2023_51_034 crossref_primary_10_3390_molecules27030789 crossref_primary_10_1111_cas_14652 crossref_primary_10_18332_tid_166110 crossref_primary_10_1093_jncics_pkaa108 crossref_primary_10_1093_humrep_dead110 crossref_primary_10_3389_fonc_2022_870086 crossref_primary_10_3390_antiox11030448 crossref_primary_10_1093_biostatistics_kxab016 crossref_primary_10_1002_cam4_3797 crossref_primary_10_23736_S0375_9393_24_18396_4 crossref_primary_10_1007_s10115_023_01862_1 crossref_primary_10_3390_ijms21239042 crossref_primary_10_1007_s10552_022_01560_3 crossref_primary_10_1093_jncics_pkad005 crossref_primary_10_1080_14779072_2021_1902306 crossref_primary_10_1111_jdi_13265 crossref_primary_10_1161_JAHA_118_008769 crossref_primary_10_1172_jci_insight_123047 crossref_primary_10_1186_s12916_019_1474_7 crossref_primary_10_1186_s12872_019_1092_5 crossref_primary_10_1080_10428194_2024_2364830 crossref_primary_10_1007_s00392_020_01615_y crossref_primary_10_3390_cells8050381 crossref_primary_10_18632_oncotarget_27814 crossref_primary_10_1155_2022_4570926 crossref_primary_10_1007_s00395_024_01046_0 crossref_primary_10_1007_s00395_024_01088_4 crossref_primary_10_1002_ehf2_14668 crossref_primary_10_1177_1538574418764055 crossref_primary_10_1016_j_jaccao_2020_12_003 crossref_primary_10_1158_1055_9965_EPI_21_0610 crossref_primary_10_3389_fnut_2022_847421 crossref_primary_10_1007_s11912_022_01212_4 crossref_primary_10_1038_s41569_022_00698_6 crossref_primary_10_1002_cbf_4018 crossref_primary_10_1007_s11912_023_01426_0 crossref_primary_10_33435_tcandtc_1102295 crossref_primary_10_1002_cam4_6603 crossref_primary_10_1007_s11010_020_04022_z crossref_primary_10_3390_biology11020300 crossref_primary_10_1016_j_jtha_2024_12_008 crossref_primary_10_1186_s12967_023_04498_5 crossref_primary_10_3390_molecules25112653 crossref_primary_10_1161_CIRCULATIONAHA_118_035516 crossref_primary_10_1093_cvr_cvae055 crossref_primary_10_1016_j_resuscitation_2022_07_032 crossref_primary_10_3390_cancers15020512 crossref_primary_10_3389_fgene_2020_00320 crossref_primary_10_4048_jbc_2024_0085 crossref_primary_10_1186_s12967_024_06027_4 crossref_primary_10_1186_s12885_024_12053_8 crossref_primary_10_1016_j_ebiom_2020_103193 crossref_primary_10_1038_s41416_022_01935_y crossref_primary_10_1016_j_ypmed_2021_106530 crossref_primary_10_1007_s11239_020_02273_7 crossref_primary_10_1111_eci_14255 crossref_primary_10_3389_fcvm_2020_00148 crossref_primary_10_1007_s11883_022_01021_x crossref_primary_10_1155_2023_2404806 crossref_primary_10_1097_HCO_0000000000000767 crossref_primary_10_1016_j_ijcard_2019_01_082 crossref_primary_10_1002_hsr2_256 crossref_primary_10_1097_FJC_0000000000000660 crossref_primary_10_1016_j_bbrep_2025_101970 crossref_primary_10_1093_cvr_cvaa244 crossref_primary_10_3390_nu12041066 crossref_primary_10_1007_s11864_022_00978_w crossref_primary_10_1186_s40959_023_00196_9 crossref_primary_10_4070_kcj_2020_0158 crossref_primary_10_3390_curroncol28050313 |
Cites_doi | 10.1016/j.vph.2015.08.012 10.1196/annals.1414.011 10.1371/journal.pone.0036565 10.1073/pnas.0911220107 10.1016/j.arcmed.2011.11.009 10.1056/NEJMp1213380 10.4239/wjd.v6.i2.352 10.1056/NEJMoa1301824 10.1056/NEJMoa043792 10.14310/horm.2002.1671 10.1073/pnas.93.12.5793 10.1179/1743132815Y.0000000008 10.3390/ijms14035560 10.1016/j.atherosclerosis.2012.12.029 10.3748/wjg.v20.i23.7137 10.1016/S0140-6736(00)04046-0 10.1097/01.mnh.0000196146.65330.ea 10.1016/j.jacc.2006.12.048 10.1172/JCI24140 10.1038/nrc3215 10.1073/pnas.1019443108 10.1161/01.STR.0000257974.06317.49 10.1111/joim.12012 10.1186/1471-2407-6-268 10.1016/S0140-6736(04)17018-9 10.1016/j.jvs.2008.10.004 10.2337/dc07-2131 10.1016/j.bbrc.2004.06.133 10.3892/ijmm.2014.1942 10.1016/0896-6273(95)90286-4 10.1161/CIRCRESAHA.108.183863 10.18632/oncotarget.2769 10.1186/1471-2350-14-8 10.1136/bmj.38415.708634.F7 10.1016/j.celrep.2015.09.028 10.1158/0008-5472.CAN-04-3025 10.1016/j.cmet.2011.03.009 10.1016/j.bcp.2004.01.020 10.1038/onc.2009.339 10.1523/JNEUROSCI.4288-03.2004 10.4049/jimmunol.1000181 10.1111/j.1748-1716.2009.01980.x 10.1074/jbc.M111.295287 10.1016/j.bbrc.2015.05.108 10.1016/S0140-6736(09)61965-6 10.1016/j.metabol.2011.10.013 10.1016/S0140-6736(09)60503-1 10.1158/1541-7786.MCR-05-0261 10.1155/2012/968040 10.1074/jbc.M110.100321 10.1159/000069792 10.1002/humu.22360 10.1186/1471-2350-10-15 10.1126/science.1136370 10.1517/14728222.2014.938051 10.1016/j.devcel.2009.06.016 10.3181/00379727-210-43942 10.1007/s12013-011-9253-x 10.2174/138945011797635803 10.1016/S0140-6736(10)61543-7 10.1038/450494a 10.1074/jbc.M212831200 10.1038/emm.2016.16 10.1016/j.atherosclerosis.2007.05.026 10.1161/CIRCULATIONAHA.107.696922 10.1007/s00592-013-0504-8 10.1111/j.1365-2141.2012.09074.x 10.1161/ATVBAHA.111.241927 10.1007/s00277-014-2236-4 10.1016/j.ccr.2012.12.008 10.1053/j.gastro.2009.01.053 10.1016/S0140-6736(98)03228-0 10.1038/labinvest.2008.97 10.1002/jcp.20472 10.2174/156652410793384187 10.1016/j.cmet.2013.01.009 10.1016/j.annepidem.2011.10.006 10.1016/S0140-6736(11)61654-1 10.1161/01.ATV.21.3.372 10.4103/2230-8210.163106 10.1016/j.tem.2005.07.009 10.1016/j.ejphar.2015.10.057 10.1007/s12020-012-9821-x 10.1074/jbc.M111.286724 10.1016/j.pharmthera.2010.11.002 10.1016/S0140-6736(05)67528-9 10.1016/S0140-6736(08)60269-X 10.1684/ecn.2011.0295 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1 10.1016/j.jacc.2014.03.049 10.1093/jnci/djs377 10.18632/genesandcancer.29 10.1016/j.ejmg.2014.10.004 10.1016/j.tem.2012.06.001 10.1016/j.yjmcc.2015.07.005 10.1517/14712598.6.3.243 10.1016/j.canlet.2013.08.014 10.1210/endo.142.7.8272 10.1097/HCO.0b013e3283470359 10.1016/S0140-6736(10)62110-1 10.1016/j.freeradbiomed.2012.02.035 10.1038/cgt.2014.16 10.1177/1474515111430928 10.1007/s00109-007-0203-4 10.1038/sj.onc.1208555 10.2353/ajpath.2009.080611 10.1002/ppul.20338 10.1016/j.gene.2015.03.062 10.1016/S0083-6729(08)00413-5 10.1016/j.bbrc.2006.06.082 10.1093/carcin/bgp127 10.1093/carcin/bgg032 10.1016/S0014-5793(02)03110-1 10.1016/j.atherosclerosis.2008.05.029 10.1016/j.bmcl.2015.08.087 10.1074/jbc.M104091200 10.1002/ijc.23173 10.1016/j.jamcollsurg.2007.01.067 10.1053/euhj.1999.1914 10.1016/j.jns.2012.07.038 10.1038/onc.2014.416 10.2174/1570161043385556 10.1016/j.cell.2013.06.030 10.1007/s10549-012-2299-7 10.1371/journal.pone.0017978 10.3109/00207454.2014.984295 10.1155/2008/431763 10.4161/cbt.8.17.9322 10.1016/j.cmet.2013.11.023 10.1016/j.jjcc.2015.05.004 10.1016/S0140-6736(11)61720-0 10.1152/ajpheart.00982.2007 10.1530/JME-13-0152 10.1113/jphysiol.2006.108324 10.1158/1940-6207.CAPR-10-0157 10.1038/ajg.2013.5 10.1038/sj.onc.1208123 10.1016/j.ehj.2003.12.007 10.1001/jama.298.10.1180 10.7150/ijms.10953 10.1210/me.2007-0421 10.1089/gtmb.2012.0295 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
DOI | 10.1016/j.atherosclerosis.2017.06.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1484 |
EndPage | 351 |
ExternalDocumentID | oai:pubmedcentral.nih.gov:6207942 PMC6207942 28624099 10_1016_j_atherosclerosis_2017_06_001 S0021915017302484 1_s2_0_S0021915017302484 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R35 HL135767 |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG 0SF AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX ACLOT CITATION ~HD AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c616t-cad185f8cdf5ff2caefcc98d72871c46c5548c46a8dd769a6522d5293584dfd33 |
IEDL.DBID | UNPAY |
ISSN | 0021-9150 1879-1484 |
IngestDate | Wed Aug 20 00:05:06 EDT 2025 Tue Sep 30 16:45:18 EDT 2025 Sat Sep 27 21:51:33 EDT 2025 Mon Jul 21 06:06:10 EDT 2025 Wed Oct 01 05:14:22 EDT 2025 Thu Apr 24 23:06:57 EDT 2025 Fri Feb 23 02:49:21 EST 2024 Tue Feb 25 19:57:36 EST 2025 Tue Aug 26 16:36:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | CVD T2DM TZDs CAD RAAS AMPK PAI-1 VSMC ACEIs/ARBs PPAR-γ WHO Signaling pathways Malignancy Atherosclerosis |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c616t-cad185f8cdf5ff2caefcc98d72871c46c5548c46a8dd769a6522d5293584dfd33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 FMK was responsible for writing the draft of the manuscript, creating the figure and tables and performing major revision of the manuscript. NS developed the idea, wrote some parts, edited the whole manuscript and supervised the whole project. CG edited the whole manuscript and wrote some parts. AI contributed in idea development and edited the manuscript. AK was responsible for editing the whole manuscript and writing some parts. MD wrote the cardio-oncology section. CF critically edited the whole manuscript and shortened the manuscript. AM was responsible for scientific support of the genetic and molecular pathways and did the major revisions. Author contributions |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.ncbi.nlm.nih.gov/pmc/articles/6207942 |
PMID | 28624099 |
PQID | 1911198889 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | unpaywall_primary_10_1016_j_atherosclerosis_2017_06_001 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6207942 proquest_miscellaneous_1911198889 pubmed_primary_28624099 crossref_citationtrail_10_1016_j_atherosclerosis_2017_06_001 crossref_primary_10_1016_j_atherosclerosis_2017_06_001 elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2017_06_001 elsevier_clinicalkeyesjournals_1_s2_0_S0021915017302484 elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2017_06_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-08-01 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2017 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | (bib5) 2002 Lee, Nathan Grantham, Trachte (bib7) 2006; 347 Paredes, Matta-Coelho, Monteiro (bib59) 2016; 15 Kang, Zhao, Liu (bib132) 2013; 17 Deshayes, Nahmias (bib8) 2005; 16 Lincoff, Wolski, Nicholls (bib57) 2007; 298 Wu, Liu, Pang (bib61) 2014; 34 Christman, Goetz, Dickerson (bib88) 2008; 294 Chogtu, Magazine, Bairy (bib142) 2015; 6 Rothwell, Price, Fowkes (bib10) 2012; 379 Chen, Ishibashi, Perrey (bib40) 2001; 21 Zhu, Hou, Pan (bib130) 2015; 125 El-Serag, Johnson, Hachem (bib139) 2009; 136 Liu, Prior, Piwnica-Worms (bib104) 2010; 107 Tong, Lin, Zhang (bib109) 2009; 10 Lu, Ouyang, Huang (bib21) 2006; 4 Decensi, Puntoni, Goodwin (bib37) 2010; 3 Vink, Schoneveld, Lamers (bib14) 2007; 195 Yan, Yang, Chen (bib47) 2014; 21 Ploplis (bib67) 2011; 12 Bian, Yu, Wang (bib66) 2015; 463 Shao, Cheng, Pingsterhaus (bib90) 2005; 115 Wang, Song, Srivastava (bib101) 2015; 29 Song, Wang, Mani (bib100) 2014; 5 Lemieux, Cagnol, Beaudry (bib106) 2015; 34 Sikka, Chen, Sethi (bib46) 2012; 2012 Monami, Dicembrini, Mannucci (bib53) 2014; 51 Lipscomb, Gotay, Snyder (bib2) 2007; 57 Olijhoek, van der Graaf, Banga (bib12) 2004; 25 Fang, Placencio, DeClerck (bib70) 2012; 104 Dormandy, Charbonnel, Eckland (bib55) 2005; 366 Connor, Baumgartner, Baumgartner (bib114) 2012; 136 Rothwell, Wilson, Elwin (bib158) 2010; 376 Tejedor, Zhu, Kaltenbach (bib117) 1995; 14 Keramati, Singh, Lin (bib86) 2011; 108 Reddy, Baskaran, Molteni (bib147) 1995; 210 Singh, De Aguiar, Naik (bib97) 2013; 17 Kavalipati, Shah, Ramakrishan (bib135) 2015; 19 Shackelford, Abt, Gerken (bib39) 2013; 23 Yoshiji, Kuriyama, Fukui (bib153) 2002; 23 Folsom, Pankow, Peacock (bib112) 2008; 31 Fleming, Kohlstedt, Busse (bib150) 2006; 15 Ando, Catalano (bib78) 2011; 8 Mani, Radhakrishnan, Wang (bib87) 2007; 315 Mughal, Kumar, Vikram (bib51) 2015; 768 Cauchi, El Achhab, Choquet (bib110) 2007; 85 Yusuf, Hawken, Ounpuu (bib71) 2004; 364 Evans, Donnelly, Emslie-Smith (bib36) 2005; 330 Thambyrajah, Townend (bib126) 2000; 21 Geng, Jin, Wu (bib54) 2009; 202 Wang, Yin, Liu (bib42) 2011; 75 Balkwill, Mantovani (bib16) 2001; 357 Chen, Li, Zhu (bib25) 2015; 85 Friedman (bib120) 2013; 14 Swinnen, Beckers, Brusselmans (bib29) 2005; 65 Xuan, Bai, Gao (bib125) 2011; 42 Li, Xu, Mihaylova (bib27) 2011; 13 Burwinkel, Shanmugam, Hemminki (bib116) 2006; 6 Kim, Kim, Kim (bib89) 2010; 185 Giri, Nath, Smith (bib28) 2004; 24 Meisse, Van de Casteele, Beauloye (bib31) 2002; 526 Pollak (bib50) 2012; 12 Alfieri, Mayosi, Park (bib160) 2014; 11 Thomas, Fenech (bib133) 2008; 79 Morrow, Foufelle, Connell (bib22) 2003; 278 Fiorentino, Zadra, Palescandolo (bib63) 2008; 88 Sattar, Preiss, Murray (bib143) 2010; 375 Garcia-Jimenez, Garcia-Martinez, Chocarro-Calvo (bib84) 2014; 52 Zhang, Li, Liu (bib105) 2010; 29 Liew, Gupta (bib127) 2015; 58 Singh, Singh, Singh (bib38) 2013; 108 Muendlein, Saely, Geller-Rhomberg (bib107) 2011; 6 Mc Menamin, Murray, Cantwell (bib9) 2012; 23 Ye, Go, Singh (bib96) 2012; 287 Sampson, Linton, Fazio (bib144) 2011; 26 Montecucco, Mach (bib134) 2009; 23 Gao, Li, Xiao (bib131) 2012; 323 Sjostrom (bib73) 2013; 273 Ino, Shibata, Kajiyama (bib151) 2006; 6 Li, Jiang, Robinson (bib30) 2003; 24 Tajik, Keshavarz, Masoudkabir (bib77) 2013; 36 Prontera, Mariani, Rossi (bib148) 1999; 81 Parekh, Galloway, Hong (bib154) 2013; 368 Erdmann, Dormandy, Charbonnel (bib56) 2007; 49 Garofalo, Surmacz (bib79) 2006; 207 Karbaschian, Hosseinzadeh-Attar, Giahi (bib75) 2013; 44 Lever, Hole, Gillis (bib145) 1998; 352 Cabarcas, Hurt, Farrar (bib23) 2010; 10 Agrawal, Febbraio, Podrez (bib15) 2007; 115 Go, Mani (bib94) 2012; 85 Giaginis, Tsantili-Kakoulidou, Theocharis (bib82) 2008; 2008 Dickens, Cherrington, McGowan (bib3) 2012; 11 Escobar, Rodriguez-Reyna, Arrieta (bib149) 2004; 2 Pateras, Giaginis, Tsigris (bib13) 2014; 18 Denning, Stoll (bib52) 2006; 41 Li (bib123) 2012; 61 (bib6) 2011 Marinou, Christodoulides, Antoniades (bib91) 2012; 23 Liu, Mani, Davis (bib93) 2008; 103 Kumar, Kumar, Prasad (bib129) 2015; 37 Pizer, Jackisch, Wood (bib65) 1996; 56 Tajik, Golpaie, Keshavarz (bib76) 2012; 35 Daar, Singer, Persad (bib4) 2007; 450 Khandanpour, Willis, Meyer (bib128) 2009; 49 Saitoh, Nagai, Nakagawa (bib32) 2004; 67 Sabatino, Pancione, Votino (bib45) 2014; 20 Hirabayashi, Baranski, Cagan (bib92) 2013; 154 Ivanova, Parolari, Myasoedova (bib43) 2015; 66 Motoshima, Goldstein, Igata (bib26) 2006; 574 Liu, Singh, Choi (bib95) 2012; 287 Domenyuk, Litovkin, Verbitskaya (bib113) 2007; 29 Hussain, Harris (bib18) 2007; 121 Mullen, Yet (bib62) 2015; 25 Hursting, Hursting (bib69) 2012; 32 Conzen (bib48) 2008; 22 Liu, Dai, Xu (bib49) 2012; 62 Tung, Wong, Yau (bib103) 2012; 7 (bib1) 2014 Wilcox, Bousser, Betteridge (bib58) 2007; 38 Sugawara, Takeuchi, Uruno (bib44) 2001; 142 Renehan, Tyson, Egger (bib72) 2008; 371 Rothwell, Fowkes, Belch (bib159) 2011; 377 Wu, Antony, Meitzler (bib20) 2014; 345 Chen, Huang, Huang (bib115) 2015; 12 Wang, Hu, Feng (bib108) 2013; 14 Keramati, Fathzadeh, Go (bib122) 2014; 370 Taylor, Cook, Sheffield (bib152) 1988; 130 Go, Srivastava, Hernandez-Ono (bib99) 2014; 19 Arafat, Gong, Chipitsyna (bib146) 2007; 204 Colotta, Allavena, Sica (bib19) 2009; 30 Corcos, Le Jossic-Corcos (bib140) 2013; 45 Chan, Cook (bib157) 2012; 379 Kallen, Lazar (bib81) 1996; 93 Yang, Ahn, Chung (bib118) 2001; 276 Simon, Rosenberg, Rodabough (bib137) 2012; 22 Shah, Mahmoudi (bib141) 2015; 86 Kundu, Surh (bib17) 2012; 52 Ntaios, Gatselis, Makaritsis (bib80) 2013; 227 Singh, Smith, Fathzadeh (bib98) 2013; 34 Nakaya, Summers, Nicholson (bib41) 2009; 174 Li, Lu, He (bib102) 2004; 23 Wang, Jiang, Li (bib111) 2015; 8 Baigent, Blackwell, Collins (bib156) 2009; 373 Bockorny, Dasanu (bib136) 2015; 94 Kim, Yang, Kim (bib35) 2016; 48 Halvorsen, Andreotti, ten Berg (bib155) 2014; 64 Ewart, Kennedy (bib24) 2011; 131 Bandyopadhyay, Pai, Watabe (bib64) 2005; 24 Xiang, Saha, Wen (bib33) 2004; 321 Hou, Chen, Shi (bib124) 2015; 565 Wang, Guan (bib34) 2009; 196 Srivastava, Zhang, Go (bib85) 2015; 13 Gao, Zheng, Rawal (bib121) 2009; 8 Schneider, Yang, Chakravarthy (bib60) 2010; 285 Golpaie, Tajik, Masoudkabir (bib74) 2011; 22 Deng, Friedman (bib119) 2014; 5 MacDonald, Tamai, He (bib83) 2009; 17 Poynter, Gruber, Higgins (bib138) 2005; 352 Attoub, Gaben, Al-Salam (bib11) 2008; 1138 Iwaki, Urano, Umemura (bib68) 2012; 157 Christman (10.1016/j.atherosclerosis.2017.06.001_bib88) 2008; 294 Tong (10.1016/j.atherosclerosis.2017.06.001_bib109) 2009; 10 Alfieri (10.1016/j.atherosclerosis.2017.06.001_bib160) 2014; 11 Tajik (10.1016/j.atherosclerosis.2017.06.001_bib77) 2013; 36 Yang (10.1016/j.atherosclerosis.2017.06.001_bib118) 2001; 276 Wilcox (10.1016/j.atherosclerosis.2017.06.001_bib58) 2007; 38 Li (10.1016/j.atherosclerosis.2017.06.001_bib27) 2011; 13 Lu (10.1016/j.atherosclerosis.2017.06.001_bib21) 2006; 4 Vink (10.1016/j.atherosclerosis.2017.06.001_bib14) 2007; 195 Marinou (10.1016/j.atherosclerosis.2017.06.001_bib91) 2012; 23 El-Serag (10.1016/j.atherosclerosis.2017.06.001_bib139) 2009; 136 Chen (10.1016/j.atherosclerosis.2017.06.001_bib25) 2015; 85 Garcia-Jimenez (10.1016/j.atherosclerosis.2017.06.001_bib84) 2014; 52 Lipscomb (10.1016/j.atherosclerosis.2017.06.001_bib2) 2007; 57 Balkwill (10.1016/j.atherosclerosis.2017.06.001_bib16) 2001; 357 Zhang (10.1016/j.atherosclerosis.2017.06.001_bib105) 2010; 29 Sabatino (10.1016/j.atherosclerosis.2017.06.001_bib45) 2014; 20 Hirabayashi (10.1016/j.atherosclerosis.2017.06.001_bib92) 2013; 154 Sugawara (10.1016/j.atherosclerosis.2017.06.001_bib44) 2001; 142 Attoub (10.1016/j.atherosclerosis.2017.06.001_bib11) 2008; 1138 Garofalo (10.1016/j.atherosclerosis.2017.06.001_bib79) 2006; 207 Mullen (10.1016/j.atherosclerosis.2017.06.001_bib62) 2015; 25 Mc Menamin (10.1016/j.atherosclerosis.2017.06.001_bib9) 2012; 23 Gao (10.1016/j.atherosclerosis.2017.06.001_bib121) 2009; 8 Hursting (10.1016/j.atherosclerosis.2017.06.001_bib69) 2012; 32 Denning (10.1016/j.atherosclerosis.2017.06.001_bib52) 2006; 41 Lincoff (10.1016/j.atherosclerosis.2017.06.001_bib57) 2007; 298 Tejedor (10.1016/j.atherosclerosis.2017.06.001_bib117) 1995; 14 Sjostrom (10.1016/j.atherosclerosis.2017.06.001_bib73) 2013; 273 Kumar (10.1016/j.atherosclerosis.2017.06.001_bib129) 2015; 37 Sampson (10.1016/j.atherosclerosis.2017.06.001_bib144) 2011; 26 Escobar (10.1016/j.atherosclerosis.2017.06.001_bib149) 2004; 2 Tung (10.1016/j.atherosclerosis.2017.06.001_bib103) 2012; 7 (10.1016/j.atherosclerosis.2017.06.001_bib5) 2002 Ntaios (10.1016/j.atherosclerosis.2017.06.001_bib80) 2013; 227 Lemieux (10.1016/j.atherosclerosis.2017.06.001_bib106) 2015; 34 Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib158) 2010; 376 Reddy (10.1016/j.atherosclerosis.2017.06.001_bib147) 1995; 210 Yoshiji (10.1016/j.atherosclerosis.2017.06.001_bib153) 2002; 23 Kallen (10.1016/j.atherosclerosis.2017.06.001_bib81) 1996; 93 Chen (10.1016/j.atherosclerosis.2017.06.001_bib115) 2015; 12 Shah (10.1016/j.atherosclerosis.2017.06.001_bib141) 2015; 86 Yusuf (10.1016/j.atherosclerosis.2017.06.001_bib71) 2004; 364 Li (10.1016/j.atherosclerosis.2017.06.001_bib123) 2012; 61 Paredes (10.1016/j.atherosclerosis.2017.06.001_bib59) 2016; 15 Corcos (10.1016/j.atherosclerosis.2017.06.001_bib140) 2013; 45 Go (10.1016/j.atherosclerosis.2017.06.001_bib94) 2012; 85 Xuan (10.1016/j.atherosclerosis.2017.06.001_bib125) 2011; 42 Li (10.1016/j.atherosclerosis.2017.06.001_bib30) 2003; 24 Sikka (10.1016/j.atherosclerosis.2017.06.001_bib46) 2012; 2012 Geng (10.1016/j.atherosclerosis.2017.06.001_bib54) 2009; 202 Fleming (10.1016/j.atherosclerosis.2017.06.001_bib150) 2006; 15 Ivanova (10.1016/j.atherosclerosis.2017.06.001_bib43) 2015; 66 Liew (10.1016/j.atherosclerosis.2017.06.001_bib127) 2015; 58 Dickens (10.1016/j.atherosclerosis.2017.06.001_bib3) 2012; 11 Ewart (10.1016/j.atherosclerosis.2017.06.001_bib24) 2011; 131 Iwaki (10.1016/j.atherosclerosis.2017.06.001_bib68) 2012; 157 Wu (10.1016/j.atherosclerosis.2017.06.001_bib20) 2014; 345 Pateras (10.1016/j.atherosclerosis.2017.06.001_bib13) 2014; 18 Cabarcas (10.1016/j.atherosclerosis.2017.06.001_bib23) 2010; 10 Parekh (10.1016/j.atherosclerosis.2017.06.001_bib154) 2013; 368 Kavalipati (10.1016/j.atherosclerosis.2017.06.001_bib135) 2015; 19 Colotta (10.1016/j.atherosclerosis.2017.06.001_bib19) 2009; 30 Xiang (10.1016/j.atherosclerosis.2017.06.001_bib33) 2004; 321 Karbaschian (10.1016/j.atherosclerosis.2017.06.001_bib75) 2013; 44 Yan (10.1016/j.atherosclerosis.2017.06.001_bib47) 2014; 21 Monami (10.1016/j.atherosclerosis.2017.06.001_bib53) 2014; 51 Bandyopadhyay (10.1016/j.atherosclerosis.2017.06.001_bib64) 2005; 24 Motoshima (10.1016/j.atherosclerosis.2017.06.001_bib26) 2006; 574 Golpaie (10.1016/j.atherosclerosis.2017.06.001_bib74) 2011; 22 Agrawal (10.1016/j.atherosclerosis.2017.06.001_bib15) 2007; 115 Morrow (10.1016/j.atherosclerosis.2017.06.001_bib22) 2003; 278 Kim (10.1016/j.atherosclerosis.2017.06.001_bib35) 2016; 48 Wang (10.1016/j.atherosclerosis.2017.06.001_bib101) 2015; 29 Burwinkel (10.1016/j.atherosclerosis.2017.06.001_bib116) 2006; 6 Mani (10.1016/j.atherosclerosis.2017.06.001_bib87) 2007; 315 Kang (10.1016/j.atherosclerosis.2017.06.001_bib132) 2013; 17 Wu (10.1016/j.atherosclerosis.2017.06.001_bib61) 2014; 34 Lee (10.1016/j.atherosclerosis.2017.06.001_bib7) 2006; 347 (10.1016/j.atherosclerosis.2017.06.001_bib6) 2011 Singh (10.1016/j.atherosclerosis.2017.06.001_bib38) 2013; 108 Liu (10.1016/j.atherosclerosis.2017.06.001_bib104) 2010; 107 Conzen (10.1016/j.atherosclerosis.2017.06.001_bib48) 2008; 22 Saitoh (10.1016/j.atherosclerosis.2017.06.001_bib32) 2004; 67 Bockorny (10.1016/j.atherosclerosis.2017.06.001_bib136) 2015; 94 Ino (10.1016/j.atherosclerosis.2017.06.001_bib151) 2006; 6 Keramati (10.1016/j.atherosclerosis.2017.06.001_bib86) 2011; 108 Prontera (10.1016/j.atherosclerosis.2017.06.001_bib148) 1999; 81 Friedman (10.1016/j.atherosclerosis.2017.06.001_bib120) 2013; 14 Simon (10.1016/j.atherosclerosis.2017.06.001_bib137) 2012; 22 Fiorentino (10.1016/j.atherosclerosis.2017.06.001_bib63) 2008; 88 Ando (10.1016/j.atherosclerosis.2017.06.001_bib78) 2011; 8 Domenyuk (10.1016/j.atherosclerosis.2017.06.001_bib113) 2007; 29 Pollak (10.1016/j.atherosclerosis.2017.06.001_bib50) 2012; 12 Liu (10.1016/j.atherosclerosis.2017.06.001_bib93) 2008; 103 Poynter (10.1016/j.atherosclerosis.2017.06.001_bib138) 2005; 352 Sattar (10.1016/j.atherosclerosis.2017.06.001_bib143) 2010; 375 Giaginis (10.1016/j.atherosclerosis.2017.06.001_bib82) 2008; 2008 Deshayes (10.1016/j.atherosclerosis.2017.06.001_bib8) 2005; 16 MacDonald (10.1016/j.atherosclerosis.2017.06.001_bib83) 2009; 17 Connor (10.1016/j.atherosclerosis.2017.06.001_bib114) 2012; 136 Dormandy (10.1016/j.atherosclerosis.2017.06.001_bib55) 2005; 366 Wang (10.1016/j.atherosclerosis.2017.06.001_bib111) 2015; 8 Kundu (10.1016/j.atherosclerosis.2017.06.001_bib17) 2012; 52 Lever (10.1016/j.atherosclerosis.2017.06.001_bib145) 1998; 352 Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib10) 2012; 379 Liu (10.1016/j.atherosclerosis.2017.06.001_bib95) 2012; 287 Gao (10.1016/j.atherosclerosis.2017.06.001_bib131) 2012; 323 Arafat (10.1016/j.atherosclerosis.2017.06.001_bib146) 2007; 204 Taylor (10.1016/j.atherosclerosis.2017.06.001_bib152) 1988; 130 Rothwell (10.1016/j.atherosclerosis.2017.06.001_bib159) 2011; 377 Decensi (10.1016/j.atherosclerosis.2017.06.001_bib37) 2010; 3 Shackelford (10.1016/j.atherosclerosis.2017.06.001_bib39) 2013; 23 Cauchi (10.1016/j.atherosclerosis.2017.06.001_bib110) 2007; 85 Swinnen (10.1016/j.atherosclerosis.2017.06.001_bib29) 2005; 65 Srivastava (10.1016/j.atherosclerosis.2017.06.001_bib85) 2015; 13 Chen (10.1016/j.atherosclerosis.2017.06.001_bib40) 2001; 21 Li (10.1016/j.atherosclerosis.2017.06.001_bib102) 2004; 23 Baigent (10.1016/j.atherosclerosis.2017.06.001_bib156) 2009; 373 (10.1016/j.atherosclerosis.2017.06.001_bib1) 2014 Schneider (10.1016/j.atherosclerosis.2017.06.001_bib60) 2010; 285 Erdmann (10.1016/j.atherosclerosis.2017.06.001_bib56) 2007; 49 Shao (10.1016/j.atherosclerosis.2017.06.001_bib90) 2005; 115 Daar (10.1016/j.atherosclerosis.2017.06.001_bib4) 2007; 450 Folsom (10.1016/j.atherosclerosis.2017.06.001_bib112) 2008; 31 Hussain (10.1016/j.atherosclerosis.2017.06.001_bib18) 2007; 121 Zhu (10.1016/j.atherosclerosis.2017.06.001_bib130) 2015; 125 Nakaya (10.1016/j.atherosclerosis.2017.06.001_bib41) 2009; 174 Meisse (10.1016/j.atherosclerosis.2017.06.001_bib31) 2002; 526 Tajik (10.1016/j.atherosclerosis.2017.06.001_bib76) 2012; 35 Chogtu (10.1016/j.atherosclerosis.2017.06.001_bib142) 2015; 6 Keramati (10.1016/j.atherosclerosis.2017.06.001_bib122) 2014; 370 Halvorsen (10.1016/j.atherosclerosis.2017.06.001_bib155) 2014; 64 Muendlein (10.1016/j.atherosclerosis.2017.06.001_bib107) 2011; 6 Khandanpour (10.1016/j.atherosclerosis.2017.06.001_bib128) 2009; 49 Mughal (10.1016/j.atherosclerosis.2017.06.001_bib51) 2015; 768 Singh (10.1016/j.atherosclerosis.2017.06.001_bib98) 2013; 34 Wang (10.1016/j.atherosclerosis.2017.06.001_bib108) 2013; 14 Liu (10.1016/j.atherosclerosis.2017.06.001_bib49) 2012; 62 Hou (10.1016/j.atherosclerosis.2017.06.001_bib124) 2015; 565 Go (10.1016/j.atherosclerosis.2017.06.001_bib99) 2014; 19 Chan (10.1016/j.atherosclerosis.2017.06.001_bib157) 2012; 379 Wang (10.1016/j.atherosclerosis.2017.06.001_bib42) 2011; 75 Wang (10.1016/j.atherosclerosis.2017.06.001_bib34) 2009; 196 Deng (10.1016/j.atherosclerosis.2017.06.001_bib119) 2014; 5 Bian (10.1016/j.atherosclerosis.2017.06.001_bib66) 2015; 463 Ploplis (10.1016/j.atherosclerosis.2017.06.001_bib67) 2011; 12 Thomas (10.1016/j.atherosclerosis.2017.06.001_bib133) 2008; 79 Montecucco (10.1016/j.atherosclerosis.2017.06.001_bib134) 2009; 23 Song (10.1016/j.atherosclerosis.2017.06.001_bib100) 2014; 5 Kim (10.1016/j.atherosclerosis.2017.06.001_bib89) 2010; 185 Ye (10.1016/j.atherosclerosis.2017.06.001_bib96) 2012; 287 Renehan (10.1016/j.atherosclerosis.2017.06.001_bib72) 2008; 371 Olijhoek (10.1016/j.atherosclerosis.2017.06.001_bib12) 2004; 25 Fang (10.1016/j.atherosclerosis.2017.06.001_bib70) 2012; 104 Evans (10.1016/j.atherosclerosis.2017.06.001_bib36) 2005; 330 Giri (10.1016/j.atherosclerosis.2017.06.001_bib28) 2004; 24 Thambyrajah (10.1016/j.atherosclerosis.2017.06.001_bib126) 2000; 21 Singh (10.1016/j.atherosclerosis.2017.06.001_bib97) 2013; 17 Pizer (10.1016/j.atherosclerosis.2017.06.001_bib65) 1996; 56 |
References_xml | – volume: 368 start-page: 204 year: 2013 end-page: 205 ident: bib154 article-title: Aspirin in the secondary prevention of cardiovascular disease publication-title: N. Engl. J. Med. – year: 2002 ident: bib5 publication-title: The World Health Report 2002-Reducing Risks, Promoting Healthy Life – volume: 12 start-page: 159 year: 2012 end-page: 169 ident: bib50 article-title: The insulin and insulin-like growth factor receptor family in neoplasia: an update publication-title: Nat. Rev. Cancer – volume: 373 start-page: 1849 year: 2009 end-page: 1860 ident: bib156 article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials publication-title: Lancet (Lond. Engl.) – volume: 13 start-page: 376 year: 2011 end-page: 388 ident: bib27 article-title: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice publication-title: Cell Metab. – volume: 364 start-page: 937 year: 2004 end-page: 952 ident: bib71 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet (Lond. Engl.) – volume: 273 start-page: 219 year: 2013 end-page: 234 ident: bib73 article-title: Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery publication-title: J. Intern. Med. – volume: 5 start-page: 11000 year: 2014 end-page: 11003 ident: bib100 article-title: Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat publication-title: Oncotarget – volume: 195 start-page: e69 year: 2007 end-page: 75 ident: bib14 article-title: HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages publication-title: Atherosclerosis – volume: 298 start-page: 1180 year: 2007 end-page: 1188 ident: bib57 article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials publication-title: Jama – volume: 352 start-page: 179 year: 1998 end-page: 184 ident: bib145 article-title: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? publication-title: Lancet (Lond. Engl.) – volume: 15 start-page: 170 year: 2016 end-page: 185 ident: bib59 article-title: Cardiovascular safety of type 2 diabetes medications: review of existing literature and clinical implications publication-title: Horm. (Athens, Greece) – volume: 121 start-page: 2373 year: 2007 end-page: 2380 ident: bib18 article-title: Inflammation and cancer: an ancient link with novel potentials publication-title: Int. J. Cancer. J. Int. du Cancer – volume: 278 start-page: 31629 year: 2003 end-page: 31639 ident: bib22 article-title: Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells publication-title: J. Biol. Chem. – volume: 51 start-page: 91 year: 2014 end-page: 101 ident: bib53 article-title: Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials publication-title: Acta Diabetol. – volume: 11 start-page: 265 year: 2012 end-page: 275 ident: bib3 article-title: Depression and health-related quality of life in people with coronary heart disease: a systematic review publication-title: Eur. J. Cardiovasc. Nurs. – volume: 2012 start-page: 968040 year: 2012 ident: bib46 article-title: Targeting PPARgamma signaling cascade for the prevention and treatment of prostate cancer publication-title: PPAR Res. – volume: 108 start-page: 881 year: 2013 end-page: 891 ident: bib38 article-title: Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis publication-title: Am. J. Gastroenterol. – volume: 34 start-page: 4914 year: 2015 end-page: 4927 ident: bib106 article-title: Oncogenic KRAS signalling promotes the Wnt/beta-catenin pathway through LRP6 in colorectal cancer publication-title: Oncogene – year: 2011 ident: bib6 publication-title: Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases – volume: 24 start-page: 827 year: 2003 end-page: 834 ident: bib30 article-title: AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression publication-title: Carcinogenesis – volume: 29 start-page: 539 year: 2010 end-page: 549 ident: bib105 article-title: Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis publication-title: Oncogene – volume: 81 start-page: 761 year: 1999 end-page: 766 ident: bib148 article-title: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma publication-title: Int. J. Cancer J. Int. du Cancer – volume: 35 start-page: 566 year: 2012 end-page: 569 ident: bib76 article-title: Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women publication-title: J. Endocrinol. Investig. – volume: 565 start-page: 39 year: 2015 end-page: 44 ident: bib124 article-title: Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis publication-title: Gene – volume: 768 start-page: 217 year: 2015 end-page: 225 ident: bib51 article-title: Effects of Thiazolidinediones on metabolism and cancer: relative influence of PPARgamma and IGF-1 signaling publication-title: Eur. J. Pharmacol. – volume: 23 start-page: 221 year: 2012 end-page: 230 ident: bib9 article-title: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review publication-title: Cancer Causes Control CCC – volume: 19 start-page: 554 year: 2015 end-page: 562 ident: bib135 article-title: Pleiotropic effects of statins publication-title: Indian J. Endocrinol. Metab. – volume: 48 start-page: e224 year: 2016 ident: bib35 article-title: AMPK activators: mechanisms of action and physiological activities publication-title: Exp. Mol. Med. – volume: 2008 start-page: 431763 year: 2008 ident: bib82 article-title: Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancer publication-title: PPAR Res. – volume: 23 start-page: 628 year: 2012 end-page: 636 ident: bib91 article-title: Wnt signaling in cardiovascular physiology publication-title: Trends Endocrinol. Metab. TEM – volume: 44 start-page: 114 year: 2013 end-page: 118 ident: bib75 article-title: Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery publication-title: Endocrine – volume: 2 start-page: 385 year: 2004 end-page: 399 ident: bib149 article-title: Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer publication-title: Curr. Vasc. Pharmacol. – volume: 174 start-page: 2007 year: 2009 end-page: 2014 ident: bib41 article-title: Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone publication-title: Am. J. Pathol. – volume: 202 start-page: 521 year: 2009 end-page: 528 ident: bib54 article-title: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials publication-title: Atherosclerosis – volume: 49 start-page: 1772 year: 2007 end-page: 1780 ident: bib56 article-title: The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study publication-title: J. Am. Coll. Cardiol. – volume: 21 start-page: 372 year: 2001 end-page: 377 ident: bib40 article-title: Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 21 start-page: 967 year: 2000 end-page: 974 ident: bib126 article-title: Homocysteine and atherothrombosis–mechanisms for injury publication-title: Eur. Heart J. – volume: 61 start-page: 846 year: 2012 end-page: 852 ident: bib123 article-title: Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis publication-title: Metab. Clin. Exp. – volume: 34 start-page: 1706 year: 2014 end-page: 1712 ident: bib61 article-title: Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-alpha publication-title: Int. J. Mol. Med. – volume: 29 start-page: 3436 year: 2015 end-page: 3445 ident: bib101 article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a publication-title: FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. – volume: 136 start-page: 593 year: 2012 end-page: 602 ident: bib114 article-title: Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study publication-title: Breast Cancer Res. Treat. – volume: 19 start-page: 209 year: 2014 end-page: 220 ident: bib99 article-title: The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue publication-title: Cell Metab. – volume: 10 start-page: 15 year: 2009 ident: bib109 article-title: Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis publication-title: BMC Med. Genet. – volume: 157 start-page: 291 year: 2012 end-page: 298 ident: bib68 article-title: PAI-1, progress in understanding the clinical problem and its aetiology publication-title: Br. J. Haematol. – volume: 357 start-page: 539 year: 2001 end-page: 545 ident: bib16 article-title: Inflammation and cancer: back to Virchow? publication-title: Lancet (Lond. Engl.) – volume: 20 start-page: 7137 year: 2014 end-page: 7151 ident: bib45 article-title: Emerging role of the beta-catenin-PPARgamma axis in the pathogenesis of colorectal cancer publication-title: World J. Gastroenterol. – volume: 17 start-page: 9 year: 2009 end-page: 26 ident: bib83 article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases publication-title: Dev. Cell – volume: 12 start-page: 1782 year: 2011 end-page: 1789 ident: bib67 article-title: Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease publication-title: Curr. Drug Targets – volume: 14 start-page: 5560 year: 2013 end-page: 5575 ident: bib120 article-title: Mirk/dyrk1B kinase in ovarian cancer publication-title: Int. J. Mol. Sci. – volume: 154 start-page: 664 year: 2013 end-page: 675 ident: bib92 article-title: Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling publication-title: Cell – volume: 196 start-page: 55 year: 2009 end-page: 63 ident: bib34 article-title: AMP-activated protein kinase and cancer publication-title: Acta Physiol. (Oxf. Engl.) – volume: 12 start-page: 243 year: 2015 end-page: 247 ident: bib115 article-title: Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer publication-title: Int. J. Med. Sci. – volume: 37 start-page: 568 year: 2015 end-page: 577 ident: bib129 article-title: Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis publication-title: Neurol. Res. – volume: 370 start-page: 1909 year: 2014 end-page: 1919 ident: bib122 article-title: A form of the metabolic syndrome associated with mutations in DYRK1B publication-title: N. Engl. J. Med. – volume: 22 start-page: 2215 year: 2008 end-page: 2228 ident: bib48 article-title: Minireview: nuclear receptors and breast cancer publication-title: Mol. Endocrinol. (Baltim. Md.) – volume: 25 start-page: 4363 year: 2015 end-page: 4369 ident: bib62 article-title: Progress in the development of fatty acid synthase inhibitors as anticancer targets publication-title: Bioorg. Med. Chem. Lett. – volume: 347 start-page: 109 year: 2006 end-page: 116 ident: bib7 article-title: Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells publication-title: Biochem. Biophys. Res. Commun. – volume: 276 start-page: 39819 year: 2001 end-page: 39824 ident: bib118 article-title: Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells publication-title: J. Biol. Chem. – volume: 131 start-page: 242 year: 2011 end-page: 253 ident: bib24 article-title: AMPK and vasculoprotection publication-title: Pharmacol. Ther. – volume: 26 start-page: 342 year: 2011 end-page: 347 ident: bib144 article-title: Are statins diabetogenic? publication-title: Curr. Opin. Cardiol. – volume: 376 start-page: 1741 year: 2010 end-page: 1750 ident: bib158 article-title: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials publication-title: Lancet (Lond. Engl.) – volume: 85 start-page: 19 year: 2012 end-page: 28 ident: bib94 article-title: Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis publication-title: Yale J. Biol. Med. – volume: 42 start-page: 677 year: 2011 end-page: 685 ident: bib125 article-title: Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls publication-title: Arch. Med. Res. – volume: 3 start-page: 1451 year: 2010 end-page: 1461 ident: bib37 article-title: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis publication-title: Cancer Prev. Res. (Phila. Pa.) – volume: 23 start-page: 143 year: 2013 end-page: 158 ident: bib39 article-title: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin publication-title: Cancer Cell – volume: 17 start-page: 412 year: 2013 end-page: 417 ident: bib132 article-title: Association of the C677T polymorphism in the MTHFR gene with hemorrhagic stroke: a meta-analysis publication-title: Genet. Test. Mol. Biomarker. – volume: 65 start-page: 2441 year: 2005 end-page: 2448 ident: bib29 article-title: Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype publication-title: Cancer Res. – volume: 371 start-page: 569 year: 2008 end-page: 578 ident: bib72 article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies publication-title: Lancet (Lond. Engl.) – volume: 7 start-page: e36565 year: 2012 ident: bib103 article-title: Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion publication-title: PLoS One – volume: 32 start-page: 1766 year: 2012 end-page: 1770 ident: bib69 article-title: Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 23 start-page: 389 year: 2009 end-page: 400 ident: bib134 article-title: Statins, ACE inhibitors and ARBs in cardiovascular disease, Best practice & research publication-title: Clin. Endocrinol. Metab. – volume: 8 start-page: 1671 year: 2009 end-page: 1679 ident: bib121 article-title: Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells publication-title: Cancer Biol. Ther. – volume: 8 start-page: 9355 year: 2015 end-page: 9361 ident: bib111 article-title: Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis publication-title: Int. J. Clin. Exp. Med. – volume: 58 start-page: 1 year: 2015 end-page: 10 ident: bib127 article-title: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases publication-title: Eur. J. Med. Genet. – volume: 330 start-page: 1304 year: 2005 end-page: 1305 ident: bib36 article-title: Metformin and reduced risk of cancer in diabetic patients publication-title: BMJ (Clin. Res. Ed.) – volume: 24 start-page: 479 year: 2004 end-page: 487 ident: bib28 article-title: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase publication-title: J. Neurosci. Off. J. Soc. Neurosci. – volume: 45 start-page: 795 year: 2013 end-page: 802 ident: bib140 article-title: Statins: perspectives in cancer therapeutics publication-title: Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver – volume: 574 start-page: 63 year: 2006 end-page: 71 ident: bib26 article-title: AMPK and cell proliferation–AMPK as a therapeutic target for atherosclerosis and cancer publication-title: J. Physiol. – volume: 13 start-page: 746 year: 2015 end-page: 759 ident: bib85 article-title: Impaired LRP6-TCF7L2 activity enhances smooth muscle cell plasticity and causes coronary artery disease publication-title: Cell Rep. – volume: 526 start-page: 38 year: 2002 end-page: 42 ident: bib31 article-title: Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells publication-title: FEBS Lett. – volume: 79 start-page: 375 year: 2008 end-page: 392 ident: bib133 article-title: Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease publication-title: Vitam. Horm. – volume: 23 start-page: 9129 year: 2004 end-page: 9135 ident: bib102 article-title: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution publication-title: Oncogene – volume: 463 start-page: 612 year: 2015 end-page: 617 ident: bib66 article-title: Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer publication-title: Biochem. Biophys. Res. Commun. – volume: 52 start-page: 2013 year: 2012 end-page: 2037 ident: bib17 article-title: Emerging avenues linking inflammation and cancer publication-title: Free Radic. Biol. Med. – volume: 6 start-page: 352 year: 2015 end-page: 357 ident: bib142 article-title: Statin use and risk of diabetes mellitus publication-title: World J. Diabetes – volume: 1138 start-page: 65 year: 2008 end-page: 72 ident: bib11 article-title: Captopril as a potential inhibitor of lung tumor growth and metastasis publication-title: Ann. N. Y. Acad. Sci. – volume: 104 start-page: 1470 year: 2012 end-page: 1484 ident: bib70 article-title: Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function publication-title: J. Natl. Cancer Inst. – volume: 285 start-page: 23398 year: 2010 end-page: 23409 ident: bib60 article-title: Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis publication-title: J. Biol. Chem. – volume: 103 start-page: 1280 year: 2008 end-page: 1288 ident: bib93 article-title: Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance publication-title: Circ. Res. – volume: 14 start-page: 8 year: 2013 ident: bib108 article-title: Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population publication-title: BMC Med. Genet. – volume: 210 start-page: 221 year: 1995 end-page: 226 ident: bib147 article-title: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells publication-title: Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York N.Y.) – volume: 23 start-page: 348 year: 2002 end-page: 356 ident: bib153 article-title: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor publication-title: Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. – volume: 94 start-page: 1 year: 2015 end-page: 12 ident: bib136 article-title: HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? publication-title: Ann. Hematol. – volume: 14 start-page: 287 year: 1995 end-page: 301 ident: bib117 article-title: minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila publication-title: Neuron – volume: 41 start-page: 23 year: 2006 end-page: 34 ident: bib52 article-title: Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease? publication-title: Pediatr. Pulmonol. – volume: 115 start-page: 1210 year: 2005 end-page: 1220 ident: bib90 article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals publication-title: J. Clin. Investig. – volume: 315 start-page: 1278 year: 2007 end-page: 1282 ident: bib87 article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors publication-title: Science – volume: 49 start-page: 711 year: 2009 end-page: 718 ident: bib128 article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis publication-title: J. Vasc. Surg. – volume: 379 start-page: 1602 year: 2012 end-page: 1612 ident: bib10 article-title: Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials publication-title: Lancet (Lond. Engl.) – volume: 52 start-page: R51 year: 2014 end-page: R66 ident: bib84 article-title: A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose publication-title: J. Mol. Endocrinol. – volume: 15 start-page: 8 year: 2006 end-page: 13 ident: bib150 article-title: The tissue renin-angiotensin system and intracellular signalling publication-title: Curr. Opin. Nephrol. Hypertens. – volume: 366 start-page: 1279 year: 2005 end-page: 1289 ident: bib55 article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial publication-title: Lancet (Lond. Engl.) – volume: 10 start-page: 744 year: 2010 end-page: 755 ident: bib23 article-title: Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease publication-title: Curr. Mol. Med. – volume: 6 start-page: e17978 year: 2011 ident: bib107 article-title: Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis publication-title: PLoS One – volume: 30 start-page: 1073 year: 2009 end-page: 1081 ident: bib19 article-title: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability publication-title: Carcinogenesis – volume: 38 start-page: 865 year: 2007 end-page: 873 ident: bib58 article-title: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04) publication-title: Stroke – volume: 93 start-page: 5793 year: 1996 end-page: 5796 ident: bib81 article-title: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 29 start-page: 152 year: 2007 end-page: 155 ident: bib113 article-title: Identification of new DNA markers of endometrial cancer in patients from the Ukrainian population publication-title: Exp. Oncol. – volume: 67 start-page: 2005 year: 2004 end-page: 2011 ident: bib32 article-title: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase publication-title: Biochem. Pharmacol. – volume: 66 start-page: 271 year: 2015 end-page: 278 ident: bib43 article-title: Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery publication-title: J. Cardiol. – volume: 108 start-page: 1914 year: 2011 end-page: 1918 ident: bib86 article-title: Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 130 start-page: 543 year: 1988 end-page: 551 ident: bib152 article-title: Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study publication-title: Am. J. Pathol. – volume: 88 start-page: 1340 year: 2008 end-page: 1348 ident: bib63 article-title: Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer publication-title: Lab. Investig. J. Tech. Methods Pathol. – volume: 115 start-page: 2939 year: 2007 end-page: 2947 ident: bib15 article-title: Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development publication-title: Circulation – volume: 21 start-page: 188 year: 2014 end-page: 193 ident: bib47 article-title: The PPARgamma agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells publication-title: Cancer Gene Ther. – volume: 22 start-page: 181 year: 2011 end-page: 186 ident: bib74 article-title: Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects publication-title: Eur. Cytokine Netw. – volume: 287 start-page: 1335 year: 2012 end-page: 1344 ident: bib96 article-title: LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake publication-title: J. Biol. Chem. – volume: 5 start-page: 337 year: 2014 end-page: 347 ident: bib119 article-title: Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells publication-title: Genes & Cancer – volume: 142 start-page: 3125 year: 2001 end-page: 3134 ident: bib44 article-title: Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells publication-title: Endocrinology – volume: 6 start-page: 243 year: 2006 end-page: 255 ident: bib151 article-title: Manipulating the angiotensin system–new approaches to the treatment of solid tumours publication-title: Expert Opin. Biol. Ther. – volume: 64 start-page: 319 year: 2014 end-page: 327 ident: bib155 article-title: Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis publication-title: J. Am. Coll. Cardiol. – volume: 25 start-page: 342 year: 2004 end-page: 348 ident: bib12 article-title: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm publication-title: Eur. Heart J. – volume: 377 start-page: 31 year: 2011 end-page: 41 ident: bib159 article-title: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials publication-title: Lancet (Lond. Engl.) – volume: 207 start-page: 12 year: 2006 end-page: 22 ident: bib79 article-title: Leptin and cancer publication-title: J. Cell. Physiol. – volume: 11 start-page: 664 year: 2014 end-page: 670 ident: bib160 article-title: Exploring unknowns in cardiology, Nature reviews publication-title: Cardiology – volume: 375 start-page: 735 year: 2010 end-page: 742 ident: bib143 article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials publication-title: Lancet (Lond. Engl.) – volume: 136 start-page: 1601 year: 2009 end-page: 1608 ident: bib139 article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes publication-title: Gastroenterology – volume: 24 start-page: 5389 year: 2005 end-page: 5395 ident: bib64 article-title: FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis publication-title: Oncogene – volume: 227 start-page: 216 year: 2013 end-page: 221 ident: bib80 article-title: Adipokines as mediators of endothelial function and atherosclerosis publication-title: Atherosclerosis – volume: 22 start-page: 17 year: 2012 end-page: 27 ident: bib137 article-title: Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk publication-title: Ann. Epidemiol. – volume: 85 start-page: 1 year: 2015 end-page: 10 ident: bib25 article-title: AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-kappaB/LOX-1 pathway publication-title: Vasc. Pharmacol. – year: 2014 ident: bib1 publication-title: Global Status Report on Noncommunicable Diseases 2014 – volume: 75 start-page: 528 year: 2011 end-page: 535 ident: bib42 article-title: Role of peroxisome proliferator-activated receptor-gamma in atherosclerosis: an update publication-title: Circ. J. Off. J. Jpn. Circ. Soc. – volume: 321 start-page: 161 year: 2004 end-page: 167 ident: bib33 article-title: AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms publication-title: Biochem. Biophys. Res. Commun. – volume: 185 start-page: 1274 year: 2010 end-page: 1282 ident: bib89 article-title: Wnt5a induces endothelial inflammation via beta-catenin-independent signaling publication-title: J. Immunol. (Baltim. Md. 1950) – volume: 62 start-page: 19 year: 2012 end-page: 27 ident: bib49 article-title: Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-gamma ligands via Wnt signaling pathway publication-title: Cell Biochem. Biophys. – volume: 352 start-page: 2184 year: 2005 end-page: 2192 ident: bib138 article-title: Statins and the risk of colorectal cancer publication-title: N. Engl. J. Med. – volume: 16 start-page: 293 year: 2005 end-page: 299 ident: bib8 article-title: Angiotensin receptors: a new role in cancer? publication-title: Trends Endocrinol. Metab. TEM – volume: 125 start-page: 885 year: 2015 end-page: 894 ident: bib130 article-title: Association between the methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and ischemic stroke in the Chinese population: a meta-analysis publication-title: Int. J. Neurosci. – volume: 17 start-page: 197 year: 2013 end-page: 209 ident: bib97 article-title: LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans publication-title: Cell Metab. – volume: 204 start-page: 996 year: 2007 end-page: 1005 ident: bib146 article-title: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma publication-title: J. Am. Coll. Surg. – volume: 107 start-page: 5136 year: 2010 end-page: 5141 ident: bib104 article-title: LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 345 start-page: 164 year: 2014 end-page: 173 ident: bib20 article-title: Molecular mechanisms underlying chronic inflammation-associated cancers publication-title: Cancer Lett. – volume: 85 start-page: 777 year: 2007 end-page: 782 ident: bib110 article-title: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis publication-title: J. Mol. Med. (Berl. Ger.) – volume: 56 start-page: 2745 year: 1996 end-page: 2747 ident: bib65 article-title: Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells publication-title: Cancer Res. – volume: 294 start-page: H2864 year: 2008 end-page: H2870 ident: bib88 article-title: Wnt5a is expressed in murine and human atherosclerotic lesions publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 18 start-page: 1089 year: 2014 end-page: 1101 ident: bib13 article-title: NF-kappaB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links publication-title: Expert Opin. Ther. Targets – volume: 287 start-page: 7213 year: 2012 end-page: 7223 ident: bib95 article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure publication-title: J. Biol. Chem. – volume: 34 start-page: 1221 year: 2013 end-page: 1225 ident: bib98 article-title: Rare nonconservative LRP6 mutations are associated with metabolic syndrome publication-title: Hum. Mutat. – volume: 6 start-page: 268 year: 2006 ident: bib116 article-title: Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study publication-title: BMC Cancer – volume: 379 start-page: 1569 year: 2012 end-page: 1571 ident: bib157 article-title: Are we ready to recommend aspirin for cancer prevention? publication-title: Lancet (Lond. Engl.) – volume: 57 start-page: 278 year: 2007 end-page: 300 ident: bib2 article-title: Patient-reported outcomes in cancer: a review of recent research and policy initiatives publication-title: CA Cancer J. Clin. – volume: 8 start-page: 263 year: 2011 end-page: 275 ident: bib78 article-title: The multifactorial role of leptin in driving the breast cancer microenvironment, Nature reviews publication-title: Endocrinology – volume: 4 start-page: 221 year: 2006 end-page: 233 ident: bib21 article-title: Inflammation, a key event in cancer development publication-title: Mol. Cancer Res. MCR – volume: 86 start-page: 147 year: 2015 end-page: 157 ident: bib141 article-title: The role of DNA damage and repair in atherosclerosis: a review publication-title: J. Mol. Cell. Cardiol. – volume: 450 start-page: 494 year: 2007 end-page: 496 ident: bib4 article-title: Grand challenges in chronic non-communicable diseases publication-title: Nature – volume: 31 start-page: 905 year: 2008 end-page: 909 ident: bib112 article-title: Variation in TCF7L2 and increased risk of colon cancer: the Aherosclerosis Risk in Communities (ARIC) Study publication-title: Diabetes Care – volume: 36 start-page: 211 year: 2013 end-page: 215 ident: bib77 article-title: Effect of diet-induced weight loss on inflammatory cytokines in obese women publication-title: J. Endocrinol. Investig. – volume: 323 start-page: 40 year: 2012 end-page: 45 ident: bib131 article-title: Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis publication-title: J. Neurol. Sci. – volume: 85 start-page: 1 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib25 article-title: AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-kappaB/LOX-1 pathway publication-title: Vasc. Pharmacol. doi: 10.1016/j.vph.2015.08.012 – volume: 1138 start-page: 65 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib11 article-title: Captopril as a potential inhibitor of lung tumor growth and metastasis publication-title: Ann. N. Y. Acad. Sci. doi: 10.1196/annals.1414.011 – volume: 7 start-page: e36565 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib103 article-title: Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion publication-title: PLoS One doi: 10.1371/journal.pone.0036565 – volume: 107 start-page: 5136 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib104 article-title: LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0911220107 – volume: 42 start-page: 677 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib125 article-title: Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2011.11.009 – volume: 368 start-page: 204 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib154 article-title: Aspirin in the secondary prevention of cardiovascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1213380 – volume: 6 start-page: 352 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib142 article-title: Statin use and risk of diabetes mellitus publication-title: World J. Diabetes doi: 10.4239/wjd.v6.i2.352 – volume: 370 start-page: 1909 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib122 article-title: A form of the metabolic syndrome associated with mutations in DYRK1B publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1301824 – volume: 352 start-page: 2184 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib138 article-title: Statins and the risk of colorectal cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa043792 – volume: 15 start-page: 170 year: 2016 ident: 10.1016/j.atherosclerosis.2017.06.001_bib59 article-title: Cardiovascular safety of type 2 diabetes medications: review of existing literature and clinical implications publication-title: Horm. (Athens, Greece) doi: 10.14310/horm.2002.1671 – volume: 93 start-page: 5793 year: 1996 ident: 10.1016/j.atherosclerosis.2017.06.001_bib81 article-title: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.93.12.5793 – volume: 37 start-page: 568 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib129 article-title: Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR gene) with ischemic stroke: a meta-analysis publication-title: Neurol. Res. doi: 10.1179/1743132815Y.0000000008 – volume: 14 start-page: 5560 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib120 article-title: Mirk/dyrk1B kinase in ovarian cancer publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms14035560 – volume: 130 start-page: 543 year: 1988 ident: 10.1016/j.atherosclerosis.2017.06.001_bib152 article-title: Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study publication-title: Am. J. Pathol. – volume: 227 start-page: 216 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib80 article-title: Adipokines as mediators of endothelial function and atherosclerosis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.12.029 – volume: 20 start-page: 7137 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib45 article-title: Emerging role of the beta-catenin-PPARgamma axis in the pathogenesis of colorectal cancer publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v20.i23.7137 – volume: 35 start-page: 566 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib76 article-title: Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women publication-title: J. Endocrinol. Investig. – volume: 8 start-page: 9355 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib111 article-title: Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis publication-title: Int. J. Clin. Exp. Med. – volume: 357 start-page: 539 year: 2001 ident: 10.1016/j.atherosclerosis.2017.06.001_bib16 article-title: Inflammation and cancer: back to Virchow? publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(00)04046-0 – volume: 15 start-page: 8 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib150 article-title: The tissue renin-angiotensin system and intracellular signalling publication-title: Curr. Opin. Nephrol. Hypertens. doi: 10.1097/01.mnh.0000196146.65330.ea – volume: 49 start-page: 1772 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib56 article-title: The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2006.12.048 – volume: 115 start-page: 1210 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib90 article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals publication-title: J. Clin. Investig. doi: 10.1172/JCI24140 – volume: 12 start-page: 159 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib50 article-title: The insulin and insulin-like growth factor receptor family in neoplasia: an update publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3215 – volume: 108 start-page: 1914 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib86 article-title: Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1019443108 – volume: 38 start-page: 865 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib58 article-title: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04) publication-title: Stroke doi: 10.1161/01.STR.0000257974.06317.49 – volume: 273 start-page: 219 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib73 article-title: Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery publication-title: J. Intern. Med. doi: 10.1111/joim.12012 – volume: 6 start-page: 268 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib116 article-title: Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study publication-title: BMC Cancer doi: 10.1186/1471-2407-6-268 – volume: 364 start-page: 937 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib71 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(04)17018-9 – volume: 49 start-page: 711 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib128 article-title: Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis publication-title: J. Vasc. Surg. doi: 10.1016/j.jvs.2008.10.004 – volume: 31 start-page: 905 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib112 article-title: Variation in TCF7L2 and increased risk of colon cancer: the Aherosclerosis Risk in Communities (ARIC) Study publication-title: Diabetes Care doi: 10.2337/dc07-2131 – volume: 321 start-page: 161 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib33 article-title: AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.06.133 – volume: 34 start-page: 1706 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib61 article-title: Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-alpha publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2014.1942 – volume: 14 start-page: 287 year: 1995 ident: 10.1016/j.atherosclerosis.2017.06.001_bib117 article-title: minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila publication-title: Neuron doi: 10.1016/0896-6273(95)90286-4 – volume: 103 start-page: 1280 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib93 article-title: Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.108.183863 – volume: 5 start-page: 11000 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib100 article-title: Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat publication-title: Oncotarget doi: 10.18632/oncotarget.2769 – volume: 14 start-page: 8 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib108 article-title: Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population publication-title: BMC Med. Genet. doi: 10.1186/1471-2350-14-8 – volume: 330 start-page: 1304 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib36 article-title: Metformin and reduced risk of cancer in diabetic patients publication-title: BMJ (Clin. Res. Ed.) doi: 10.1136/bmj.38415.708634.F7 – volume: 13 start-page: 746 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib85 article-title: Impaired LRP6-TCF7L2 activity enhances smooth muscle cell plasticity and causes coronary artery disease publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.09.028 – volume: 65 start-page: 2441 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib29 article-title: Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-3025 – volume: 13 start-page: 376 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib27 article-title: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.03.009 – volume: 67 start-page: 2005 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib32 article-title: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2004.01.020 – volume: 57 start-page: 278 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib2 article-title: Patient-reported outcomes in cancer: a review of recent research and policy initiatives publication-title: CA Cancer J. Clin. – volume: 29 start-page: 539 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib105 article-title: Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis publication-title: Oncogene doi: 10.1038/onc.2009.339 – volume: 24 start-page: 479 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib28 article-title: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase publication-title: J. Neurosci. Off. J. Soc. Neurosci. doi: 10.1523/JNEUROSCI.4288-03.2004 – volume: 185 start-page: 1274 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib89 article-title: Wnt5a induces endothelial inflammation via beta-catenin-independent signaling publication-title: J. Immunol. (Baltim. Md. 1950) doi: 10.4049/jimmunol.1000181 – volume: 196 start-page: 55 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib34 article-title: AMP-activated protein kinase and cancer publication-title: Acta Physiol. (Oxf. Engl.) doi: 10.1111/j.1748-1716.2009.01980.x – volume: 287 start-page: 1335 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib96 article-title: LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.295287 – volume: 463 start-page: 612 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib66 article-title: Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.05.108 – volume: 375 start-page: 735 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib143 article-title: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(09)61965-6 – volume: 61 start-page: 846 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib123 article-title: Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis publication-title: Metab. Clin. Exp. doi: 10.1016/j.metabol.2011.10.013 – volume: 373 start-page: 1849 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib156 article-title: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(09)60503-1 – volume: 4 start-page: 221 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib21 article-title: Inflammation, a key event in cancer development publication-title: Mol. Cancer Res. MCR doi: 10.1158/1541-7786.MCR-05-0261 – volume: 2012 start-page: 968040 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib46 article-title: Targeting PPARgamma signaling cascade for the prevention and treatment of prostate cancer publication-title: PPAR Res. doi: 10.1155/2012/968040 – volume: 285 start-page: 23398 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib60 article-title: Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.100321 – volume: 23 start-page: 348 year: 2002 ident: 10.1016/j.atherosclerosis.2017.06.001_bib153 article-title: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor publication-title: Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. doi: 10.1159/000069792 – volume: 34 start-page: 1221 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib98 article-title: Rare nonconservative LRP6 mutations are associated with metabolic syndrome publication-title: Hum. Mutat. doi: 10.1002/humu.22360 – volume: 10 start-page: 15 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib109 article-title: Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis publication-title: BMC Med. Genet. doi: 10.1186/1471-2350-10-15 – volume: 315 start-page: 1278 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib87 article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors publication-title: Science doi: 10.1126/science.1136370 – volume: 18 start-page: 1089 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib13 article-title: NF-kappaB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links publication-title: Expert Opin. Ther. Targets doi: 10.1517/14728222.2014.938051 – volume: 17 start-page: 9 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib83 article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases publication-title: Dev. Cell doi: 10.1016/j.devcel.2009.06.016 – volume: 210 start-page: 221 year: 1995 ident: 10.1016/j.atherosclerosis.2017.06.001_bib147 article-title: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells publication-title: Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York N.Y.) doi: 10.3181/00379727-210-43942 – volume: 62 start-page: 19 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib49 article-title: Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-gamma ligands via Wnt signaling pathway publication-title: Cell Biochem. Biophys. doi: 10.1007/s12013-011-9253-x – volume: 12 start-page: 1782 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib67 article-title: Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease publication-title: Curr. Drug Targets doi: 10.2174/138945011797635803 – volume: 376 start-page: 1741 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib158 article-title: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(10)61543-7 – volume: 450 start-page: 494 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib4 article-title: Grand challenges in chronic non-communicable diseases publication-title: Nature doi: 10.1038/450494a – volume: 278 start-page: 31629 year: 2003 ident: 10.1016/j.atherosclerosis.2017.06.001_bib22 article-title: Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212831200 – volume: 48 start-page: e224 year: 2016 ident: 10.1016/j.atherosclerosis.2017.06.001_bib35 article-title: AMPK activators: mechanisms of action and physiological activities publication-title: Exp. Mol. Med. doi: 10.1038/emm.2016.16 – volume: 195 start-page: e69 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib14 article-title: HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.05.026 – volume: 115 start-page: 2939 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib15 article-title: Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.696922 – volume: 51 start-page: 91 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib53 article-title: Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials publication-title: Acta Diabetol. doi: 10.1007/s00592-013-0504-8 – volume: 157 start-page: 291 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib68 article-title: PAI-1, progress in understanding the clinical problem and its aetiology publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.2012.09074.x – volume: 32 start-page: 1766 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib69 article-title: Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.111.241927 – year: 2002 ident: 10.1016/j.atherosclerosis.2017.06.001_bib5 – volume: 8 start-page: 263 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib78 article-title: The multifactorial role of leptin in driving the breast cancer microenvironment, Nature reviews publication-title: Endocrinology – volume: 29 start-page: 152 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib113 article-title: Identification of new DNA markers of endometrial cancer in patients from the Ukrainian population publication-title: Exp. Oncol. – volume: 94 start-page: 1 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib136 article-title: HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? publication-title: Ann. Hematol. doi: 10.1007/s00277-014-2236-4 – volume: 23 start-page: 143 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib39 article-title: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.12.008 – volume: 136 start-page: 1601 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib139 article-title: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.01.053 – volume: 352 start-page: 179 year: 1998 ident: 10.1016/j.atherosclerosis.2017.06.001_bib145 article-title: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(98)03228-0 – volume: 75 start-page: 528 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib42 article-title: Role of peroxisome proliferator-activated receptor-gamma in atherosclerosis: an update publication-title: Circ. J. Off. J. Jpn. Circ. Soc. – volume: 88 start-page: 1340 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib63 article-title: Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer publication-title: Lab. Investig. J. Tech. Methods Pathol. doi: 10.1038/labinvest.2008.97 – volume: 207 start-page: 12 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib79 article-title: Leptin and cancer publication-title: J. Cell. Physiol. doi: 10.1002/jcp.20472 – volume: 10 start-page: 744 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib23 article-title: Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease publication-title: Curr. Mol. Med. doi: 10.2174/156652410793384187 – volume: 17 start-page: 197 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib97 article-title: LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.01.009 – volume: 23 start-page: 389 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib134 article-title: Statins, ACE inhibitors and ARBs in cardiovascular disease, Best practice & research publication-title: Clin. Endocrinol. Metab. – volume: 22 start-page: 17 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib137 article-title: Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk publication-title: Ann. Epidemiol. doi: 10.1016/j.annepidem.2011.10.006 – volume: 56 start-page: 2745 year: 1996 ident: 10.1016/j.atherosclerosis.2017.06.001_bib65 article-title: Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells publication-title: Cancer Res. – volume: 379 start-page: 1569 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib157 article-title: Are we ready to recommend aspirin for cancer prevention? publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(11)61654-1 – volume: 21 start-page: 372 year: 2001 ident: 10.1016/j.atherosclerosis.2017.06.001_bib40 article-title: Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.21.3.372 – volume: 19 start-page: 554 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib135 article-title: Pleiotropic effects of statins publication-title: Indian J. Endocrinol. Metab. doi: 10.4103/2230-8210.163106 – volume: 16 start-page: 293 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib8 article-title: Angiotensin receptors: a new role in cancer? publication-title: Trends Endocrinol. Metab. TEM doi: 10.1016/j.tem.2005.07.009 – volume: 768 start-page: 217 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib51 article-title: Effects of Thiazolidinediones on metabolism and cancer: relative influence of PPARgamma and IGF-1 signaling publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.10.057 – volume: 44 start-page: 114 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib75 article-title: Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery publication-title: Endocrine doi: 10.1007/s12020-012-9821-x – volume: 287 start-page: 7213 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib95 article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.286724 – volume: 131 start-page: 242 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib24 article-title: AMPK and vasculoprotection publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2010.11.002 – volume: 366 start-page: 1279 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib55 article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(05)67528-9 – volume: 371 start-page: 569 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib72 article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(08)60269-X – volume: 22 start-page: 181 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib74 article-title: Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects publication-title: Eur. Cytokine Netw. doi: 10.1684/ecn.2011.0295 – volume: 81 start-page: 761 year: 1999 ident: 10.1016/j.atherosclerosis.2017.06.001_bib148 article-title: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma publication-title: Int. J. Cancer J. Int. du Cancer doi: 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1 – volume: 64 start-page: 319 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib155 article-title: Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2014.03.049 – volume: 104 start-page: 1470 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib70 article-title: Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djs377 – volume: 5 start-page: 337 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib119 article-title: Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells publication-title: Genes & Cancer doi: 10.18632/genesandcancer.29 – volume: 58 start-page: 1 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib127 article-title: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases publication-title: Eur. J. Med. Genet. doi: 10.1016/j.ejmg.2014.10.004 – volume: 23 start-page: 628 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib91 article-title: Wnt signaling in cardiovascular physiology publication-title: Trends Endocrinol. Metab. TEM doi: 10.1016/j.tem.2012.06.001 – volume: 86 start-page: 147 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib141 article-title: The role of DNA damage and repair in atherosclerosis: a review publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2015.07.005 – volume: 6 start-page: 243 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib151 article-title: Manipulating the angiotensin system–new approaches to the treatment of solid tumours publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.6.3.243 – volume: 345 start-page: 164 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib20 article-title: Molecular mechanisms underlying chronic inflammation-associated cancers publication-title: Cancer Lett. doi: 10.1016/j.canlet.2013.08.014 – volume: 142 start-page: 3125 year: 2001 ident: 10.1016/j.atherosclerosis.2017.06.001_bib44 article-title: Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells publication-title: Endocrinology doi: 10.1210/endo.142.7.8272 – volume: 45 start-page: 795 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib140 article-title: Statins: perspectives in cancer therapeutics publication-title: Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver – volume: 26 start-page: 342 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib144 article-title: Are statins diabetogenic? publication-title: Curr. Opin. Cardiol. doi: 10.1097/HCO.0b013e3283470359 – volume: 377 start-page: 31 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib159 article-title: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(10)62110-1 – volume: 52 start-page: 2013 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib17 article-title: Emerging avenues linking inflammation and cancer publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2012.02.035 – volume: 21 start-page: 188 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib47 article-title: The PPARgamma agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells publication-title: Cancer Gene Ther. doi: 10.1038/cgt.2014.16 – volume: 11 start-page: 265 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib3 article-title: Depression and health-related quality of life in people with coronary heart disease: a systematic review publication-title: Eur. J. Cardiovasc. Nurs. doi: 10.1177/1474515111430928 – volume: 85 start-page: 777 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib110 article-title: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis publication-title: J. Mol. Med. (Berl. Ger.) doi: 10.1007/s00109-007-0203-4 – volume: 24 start-page: 5389 year: 2005 ident: 10.1016/j.atherosclerosis.2017.06.001_bib64 article-title: FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis publication-title: Oncogene doi: 10.1038/sj.onc.1208555 – volume: 174 start-page: 2007 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib41 article-title: Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2009.080611 – volume: 41 start-page: 23 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib52 article-title: Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease? publication-title: Pediatr. Pulmonol. doi: 10.1002/ppul.20338 – volume: 565 start-page: 39 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib124 article-title: Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-analysis publication-title: Gene doi: 10.1016/j.gene.2015.03.062 – volume: 79 start-page: 375 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib133 article-title: Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease publication-title: Vitam. Horm. doi: 10.1016/S0083-6729(08)00413-5 – volume: 347 start-page: 109 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib7 article-title: Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2006.06.082 – volume: 30 start-page: 1073 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib19 article-title: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability publication-title: Carcinogenesis doi: 10.1093/carcin/bgp127 – volume: 24 start-page: 827 year: 2003 ident: 10.1016/j.atherosclerosis.2017.06.001_bib30 article-title: AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression publication-title: Carcinogenesis doi: 10.1093/carcin/bgg032 – volume: 526 start-page: 38 year: 2002 ident: 10.1016/j.atherosclerosis.2017.06.001_bib31 article-title: Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells publication-title: FEBS Lett. doi: 10.1016/S0014-5793(02)03110-1 – volume: 202 start-page: 521 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib54 article-title: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.05.029 – volume: 25 start-page: 4363 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib62 article-title: Progress in the development of fatty acid synthase inhibitors as anticancer targets publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2015.08.087 – volume: 276 start-page: 39819 year: 2001 ident: 10.1016/j.atherosclerosis.2017.06.001_bib118 article-title: Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M104091200 – volume: 121 start-page: 2373 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib18 article-title: Inflammation and cancer: an ancient link with novel potentials publication-title: Int. J. Cancer. J. Int. du Cancer doi: 10.1002/ijc.23173 – volume: 204 start-page: 996 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib146 article-title: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma publication-title: J. Am. Coll. Surg. doi: 10.1016/j.jamcollsurg.2007.01.067 – year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib1 – volume: 11 start-page: 664 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib160 article-title: Exploring unknowns in cardiology, Nature reviews publication-title: Cardiology – volume: 21 start-page: 967 year: 2000 ident: 10.1016/j.atherosclerosis.2017.06.001_bib126 article-title: Homocysteine and atherothrombosis–mechanisms for injury publication-title: Eur. Heart J. doi: 10.1053/euhj.1999.1914 – volume: 323 start-page: 40 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib131 article-title: Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2012.07.038 – volume: 34 start-page: 4914 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib106 article-title: Oncogenic KRAS signalling promotes the Wnt/beta-catenin pathway through LRP6 in colorectal cancer publication-title: Oncogene doi: 10.1038/onc.2014.416 – volume: 2 start-page: 385 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib149 article-title: Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer publication-title: Curr. Vasc. Pharmacol. doi: 10.2174/1570161043385556 – volume: 154 start-page: 664 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib92 article-title: Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling publication-title: Cell doi: 10.1016/j.cell.2013.06.030 – volume: 136 start-page: 593 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib114 article-title: Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-012-2299-7 – volume: 6 start-page: e17978 year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib107 article-title: Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis publication-title: PLoS One doi: 10.1371/journal.pone.0017978 – volume: 125 start-page: 885 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib130 article-title: Association between the methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and ischemic stroke in the Chinese population: a meta-analysis publication-title: Int. J. Neurosci. doi: 10.3109/00207454.2014.984295 – volume: 29 start-page: 3436 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib101 article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a publication-title: FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. – volume: 2008 start-page: 431763 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib82 article-title: Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancer publication-title: PPAR Res. doi: 10.1155/2008/431763 – volume: 8 start-page: 1671 year: 2009 ident: 10.1016/j.atherosclerosis.2017.06.001_bib121 article-title: Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.8.17.9322 – volume: 19 start-page: 209 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib99 article-title: The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.11.023 – volume: 66 start-page: 271 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib43 article-title: Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery publication-title: J. Cardiol. doi: 10.1016/j.jjcc.2015.05.004 – year: 2011 ident: 10.1016/j.atherosclerosis.2017.06.001_bib6 – volume: 379 start-page: 1602 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib10 article-title: Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials publication-title: Lancet (Lond. Engl.) doi: 10.1016/S0140-6736(11)61720-0 – volume: 294 start-page: H2864 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib88 article-title: Wnt5a is expressed in murine and human atherosclerotic lesions publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00982.2007 – volume: 52 start-page: R51 year: 2014 ident: 10.1016/j.atherosclerosis.2017.06.001_bib84 article-title: A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose publication-title: J. Mol. Endocrinol. doi: 10.1530/JME-13-0152 – volume: 574 start-page: 63 year: 2006 ident: 10.1016/j.atherosclerosis.2017.06.001_bib26 article-title: AMPK and cell proliferation–AMPK as a therapeutic target for atherosclerosis and cancer publication-title: J. Physiol. doi: 10.1113/jphysiol.2006.108324 – volume: 3 start-page: 1451 year: 2010 ident: 10.1016/j.atherosclerosis.2017.06.001_bib37 article-title: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis publication-title: Cancer Prev. Res. (Phila. Pa.) doi: 10.1158/1940-6207.CAPR-10-0157 – volume: 108 start-page: 881 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib38 article-title: Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis publication-title: Am. J. Gastroenterol. doi: 10.1038/ajg.2013.5 – volume: 23 start-page: 9129 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib102 article-title: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution publication-title: Oncogene doi: 10.1038/sj.onc.1208123 – volume: 25 start-page: 342 year: 2004 ident: 10.1016/j.atherosclerosis.2017.06.001_bib12 article-title: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm publication-title: Eur. Heart J. doi: 10.1016/j.ehj.2003.12.007 – volume: 23 start-page: 221 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib9 article-title: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review publication-title: Cancer Causes Control CCC – volume: 298 start-page: 1180 year: 2007 ident: 10.1016/j.atherosclerosis.2017.06.001_bib57 article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials publication-title: Jama doi: 10.1001/jama.298.10.1180 – volume: 12 start-page: 243 year: 2015 ident: 10.1016/j.atherosclerosis.2017.06.001_bib115 article-title: Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.10953 – volume: 36 start-page: 211 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib77 article-title: Effect of diet-induced weight loss on inflammatory cytokines in obese women publication-title: J. Endocrinol. Investig. – volume: 22 start-page: 2215 year: 2008 ident: 10.1016/j.atherosclerosis.2017.06.001_bib48 article-title: Minireview: nuclear receptors and breast cancer publication-title: Mol. Endocrinol. (Baltim. Md.) doi: 10.1210/me.2007-0421 – volume: 17 start-page: 412 year: 2013 ident: 10.1016/j.atherosclerosis.2017.06.001_bib132 article-title: Association of the C677T polymorphism in the MTHFR gene with hemorrhagic stroke: a meta-analysis publication-title: Genet. Test. Mol. Biomarker. doi: 10.1089/gtmb.2012.0295 – volume: 85 start-page: 19 year: 2012 ident: 10.1016/j.atherosclerosis.2017.06.001_bib94 article-title: Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis publication-title: Yale J. Biol. Med. |
SSID | ssj0004718 |
Score | 2.557175 |
SecondaryResourceType | review_article |
Snippet | Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are... Abstract Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 343 |
SubjectTerms | Animals Anticarcinogenic Agents - therapeutic use Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Cardiovascular Cardiovascular Agents - therapeutic use Cardiovascular Diseases - genetics Cardiovascular Diseases - metabolism Cardiovascular Diseases - pathology Cardiovascular Diseases - prevention & control Cardiovascular System - drug effects Cardiovascular System - metabolism Cardiovascular System - pathology Cell Transformation, Neoplastic - drug effects Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Cell Transformation, Neoplastic - pathology Gene Expression Regulation, Neoplastic Humans Neoplasms - genetics Neoplasms - metabolism Neoplasms - pathology Neoplasms - prevention & control Risk Factors Signal Transduction - drug effects |
SummonAdditionalLinks | – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dT9sw8ARFgr1MbOyj40OeNB4L2EkdB00TqAJ1TPAEEm-WayciqEoj0grx73fXOCmlIIF4aZom5zR35_vwfRjgF5exIFeiYw36JuEAvw1Q83SMVAOcWrTsQEsD5xeyfxWeXXevl6BX18JQWqWX_ZVMn0pr_8u-x-Z-kWVU44uzDe0ZjkwqQhUuw4oIYi5asHL891__YlYeGfFKIFM2AgKswu4szWtqZ41KHBU_M2rgzaO9KkLxkqpaNEUXMyrXJnlhHu7NcPhIXZ2uw0dvZ7Lj6lU-wVKSf4bVcx9J3wDXm0tEZT5Qw0zumCVOuDtk9Y6jDA1bVt5QqnpzH-1kfG8eyilAMet_nVlW-K5Qo_wLXJ2eXPb6Hb_jQsdKLsdIMIf6O1XWpd00FdYkqbWxchH5VTaUFo0PhUejnItkbCRab64rKJYautQFwVdo5aM8-Q5MILVVrIwL0oR8VBM4ZAvXpYUrqzhvw-8audr6duS0K8ZQ13lnt_oJbTTRRld5eG2QDXhR9eV4LeCfmpK6Lj5FcalRg7x2gOi5AZLST_5Sc10KfaAXGLQNRw3kHI-_5eE_a-bTKAcouGPyZDTBh5LWihXivA3fKmZsECOoCghdAfzrc2za3EA9xuev5NnNtNe4FAcosQVCNgz9Nnz_eP9Lb8IHOqvSLregNb6bJNtoCo4HO36q_wdRIWOs priority: 102 providerName: Elsevier |
Title | Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0021915017302484 https://www.clinicalkey.es/playcontent/1-s2.0-S0021915017302484 https://dx.doi.org/10.1016/j.atherosclerosis.2017.06.001 https://www.ncbi.nlm.nih.gov/pubmed/28624099 https://www.proquest.com/docview/1911198889 https://pubmed.ncbi.nlm.nih.gov/PMC6207942 https://www.ncbi.nlm.nih.gov/pmc/articles/6207942 |
UnpaywallVersion | submittedVersion |
Volume | 263 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 1879-1484 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 1879-1484 databaseCode: ACRLP dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 1879-1484 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 1879-1484 databaseCode: AIKHN dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 1879-1484 databaseCode: AKRWK dateStart: 19700101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NVhq88D0oH1WQ4DHZnCaugxCimpgKaBVCVBpPlmMnWqFLo6XVNB7427mLnYxuIK28tI2Scxr75_Od75c7gJeMJyG5Er5W6JtEKf5KceXxFRcpTi3adqCtgcMJH0-jj0fx0Raw5l2YmrSv01lQzE-CYnZccyvLE73b8MR2ebiHGEKt2-UxOswd6E4nn0ffLJWD4eStq7JSEW0fTf1oG15dcLpqo2pRYTv4OaNs3WwY2HDEv9alq3bnVfrkzVVRqvMzNZ__sTYd3IEvzVNZSsqPYLVMA_3zUsLHjR77Ltx2lqo3sqfuwVZW3IftQxeLfwBmf43K6rlQj6cK42nC0ulrr6lZ6qFp7FXHRHZvr6NayGfqvKoFyosM2jPtlS6v1KJ4CNOD91_3x76r2eBrzvgSh9ygBZALbfI4z0OtslzrRJgheWY64hrNF4HfShgz5IniaP-ZOKRobGRyMxjsQKdYFNlj8ELEi0iEMoM8Iy9XDQwCy8S09aUFYz1404yY1C6hOdXVmMuGufZdXhpwSQMuLZOvB7wVL21mj-sKvm3gIZvXV1HhSlyDrtvA8G8NZJVTH5VksgrlnqRIOiNAM9TDIYK5B-9aSWchWctnk5u_aBAtUZNQeEgV2WKFN6V1LxHY5z14ZBHedkxI7xGhM4F_fQ377QWUpXz9DKK4zlbugIuS7SzZrL-f_LfkU7hFR5av-Qw6y9NV9hxtyGXahxvBL9aH7ujDp_Gk73TIbw6wej0 |
linkProvider | Unpaywall |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dT9sw8MSKBLwgNrZRPjZPYo8dxEkcB6EJVA2VQfsEEm-WayciU5VGpBXi33PXOOm6bhJoL02V5Jzk7nwfvg8DHHoi5uRKdIxG3yQY4r8hap6OFnKIU4uWHWhpoD8Qvdvg5114twLduhaG0iqd7K9k-kxauzNHDptHRZZRjS_ONrRnPGRSHsjgDawGoR_LFqyeX171BvPyyMirBDJlIyDAGnydp3nN7KxxiaPib0YNvL3oWxWh-JeqWjZFlzMq16d5oZ8e9Wj0m7q62IJNZ2ey8-pT3sJKkr-Dtb6LpG-D7S4kojIXqGE6t8wQJzycsHrHUYaGLSvvKVW9uY92Mn7UT-UMoJj3v84MK1xXqHH-Hm4vftx0ex2340LHCE9MkGAW9XcqjU3DNOVGJ6kxsbQR-VUmEAaND4lHLa2NRKwFWm825BRLDWxqff8DtPJxnuwA40htGUtt_TQhH1X7FtnChrRwZaTnteG0Rq4yrh057YoxUnXe2S_1B20U0UZVeXhtEA14UfXleCng95qSqi4-RXGpUIO8dIDobwMkpZv8pfJUydWxWmLQNpw1kAs8_pqHf6mZT6EcoOCOzpPxFB9KWiuWiPM2fKyYsUEMpyogdAXw1RfYtLmBeowvXsmz-1mvccGPUWJzhGwY-nX43v3_j_4M672b_rW6vhxc7cEGXalSMPehNXmYJgdoFk6Gn9y0fwZNPGai |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED9KCt1e9v2RfaHB9mi3cmxFHmOslJUyaBljge5JyJJNs6WKqRNK99fvzpbcpd2g2UsSY58cSz-d7nQ_3wG84SJPyJWIjEbfJC3wV4ErT6SFLHBq0bYDbQ0cHomDSfr5ODveAB7ehWlJ-6aYxm52GrvpScutrE_NduCJbYtkBzGEWndTZOgwD2BzcvRl93tH5eA4eduqrFREO0JTP92Ct5ecrtaomjfYDn5OKVs3H8ddOOJf69J1u_M6ffLW0tX64lzPZn-sTft34Wt4qo6S8jNeLorY_LqS8HGtx74Hd7ylyna7U_dho3QPYOvQx-Ifgt1bobIyH-ph2llmCEtn71ioWcrQNGbNCZHd--uoFvK5vmhagfoyg_bUsNrnlZq7RzDZ__Rt7yDyNRsiI7hY4JBbtAAqaWyVVVVidFkZk0s7Js_MpMKg-SLxW0trxyLXAu0_myUUjU1tZUejxzBwc1c-BZYgXmQutR1VJXm5emQRWDajrS8jOR_C-zBiyviE5lRXY6YCc-2HujLgigZcdUy-IYhevO4ye9xU8EOAhwqvr6LCVbgG3bSB8d8aKBuvPhrFVZOoHUWRdE6A5qiHEwTzED72kt5C6iyfdW7-OiBaoSah8JB25XyJN6V1L5fY50N40iG875iE3iNCZwL_-gr2-wsoS_nqGURxm63cAxcl-1myXn8_-2_J53Cbjjq-5gsYLM6W5Uu0IRfFK681fgN2PHex |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiovascular+disease+and+cancer%3A+Evidence+for+shared+disease+pathways+and+pharmacologic+prevention&rft.jtitle=Atherosclerosis&rft.au=Masoudkabir%2C+Farzad&rft.au=Sarrafzadegan%2C+Nizal&rft.au=Gotay%2C+Carolyn&rft.au=Ignaszewski%2C+Andrew&rft.date=2017-08-01&rft.issn=1879-1484&rft.eissn=1879-1484&rft.volume=263&rft.spage=343&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2017.06.001&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon |